Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer

Background: Immunotherapy (IT) has led to improved survival in several common cancers but success in pancreatic ductal adenocarcinoma (PDAC) has been limited. We analyzed if combination IT–chemotherapy (IT-CT) is associated with improved survival compared with chemotherapy alone (CT) in patients wit...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Pancreat Cancer
Main Authors: Hue, Jonathan J., Bingmer, Katherine, Sugumar, Kavin, Markt, Sarah C., Rothermel, Luke D., Hardacre, Jeffrey M., Ammori, John B., Winter, Jordan M., Ocuin, Lee M.
格式: Artigo
語言:Inglês
出版: Mary Ann Liebert, Inc., publishers 2021
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080907/
https://ncbi.nlm.nih.gov/pubmed/33937617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/pancan.2021.0003
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍